Assessing and Resolving Findings of Sex Chromosome Discordance in Genetic Testing
The Journal of Applied Laboratory Medicine · 2026
DOI: 10.1093/jalm/jfaf167 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, 2026. Verfasst von Kyle T Salsbery und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN, United States. Hauptthemen laut MEDLINE: Genetic Testing, Chromosomes, Human, Y, Chromosomes, Human, X, Sex Chromosome Aberrations. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
X and Y chromosome analysis is a critical component of genetic testing, used both diagnostically and as a quality control (QC) metric. Discordances between expected and observed sex chromosome data can arise due to mislabeling, demographic data errors, transplant history, or biological variations. Such discordances pose challenges to laboratories and affect patient care, particularly in marginalized populations and unique clinical contexts.
Methods
We reviewed cases of sex chromosome discordance identified at our laboratory from January 2021 through August 2023. Cases spanned various testing methods and were categorized by the root cause, including mislabeling, sample mix-ups, transgender individuals, stem cell transplants, and unexplained causes. Case outcomes were assessed, and potential resolutions were analyzed.
Results
Among 65 cases identified, the leading cause of discordance was mislabeling (n = 20, 31%), followed by other/not identified (n = 16, 25%), sample mix-ups (n = 13, 20%), transgender individuals (n = 9, 14%), and stem cell transplants (n = 7, 11%). Cases required additional QC processes such as reanalysis, clinician contact, and occasionally sample re-collection. The process extended turnaround times by up to 13 business days. Detailed case reviews highlighted the challenges and implications of managing these discordances, emphasizing the importance of accurate data transmission and inclusive practices.
Conclusion
Using X and Y chromosome data as a QC metric can identify critical errors but also introduces limitations and bias. Improved standardization, inclusive practices, and alternative QC methods are necessary to ensure accuracy and equitable patient care. Collaborative efforts are required to address demographic complexities and reduce testing delays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN, United States.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
- Division of Clinical Cytogenetics, Center for Advanced Molecular Diagnostics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
- Department of Clinical Genomics, Mayo Clinic, Rochester, MN, United States.
ORCID-Profile: Lauren A Choate
Zitieren
APA
Salsbery, K. T., Essendrup, A. A., Flynn Gilmer, H. C., Nelson-Holte, M. H., Choate, L. A., & Niu, Z. (2026). Assessing and Resolving Findings of Sex Chromosome Discordance in Genetic Testing. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfaf167
Vancouver
Salsbery KT, Essendrup AA, Flynn Gilmer HC, Nelson-Holte MH, Choate LA, Niu Z. Assessing and Resolving Findings of Sex Chromosome Discordance in Genetic Testing. The Journal of Applied Laboratory Medicine. 2026. doi:10.1093/jalm/jfaf167
BibTeX
@article{Salsbery2026,
author = {Salsbery, Kyle T and Essendrup, Anna A and Flynn Gilmer, Heather C and Nelson-Holte, Molly H and Choate, Lauren A and Niu, Zhiyv},
title = {Assessing and Resolving Findings of Sex Chromosome Discordance in Genetic Testing},
journal = {The Journal of Applied Laboratory Medicine},
year = {2026},
doi = {10.1093/jalm/jfaf167}
}
EUVIMED